Conformational analysis of clostridium difficile toxin B and its implications for substrate recognition

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Swett, Rebecca ^a   Cisneros, G Andrés ^a   Feig, Andrew L ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN B; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CATALYSIS; CLOSTRIDIUM DIFFICILE; CONFORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HINGE REGION; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

BACTERIAL PROTEINS; BACTERIAL TOXINS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; PRINCIPAL COMPONENT ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RHOA GTP-BINDING PROTEIN; THERMODYNAMICS; TIME FACTORS;

CLOSTRIDIUM DIFFICILE;

EID: 84864184183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041518     Document Type: Article

References (62)

1. Pepin J, Valiquette L, Cossette B, (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173: 1037-1042.
2. Hookman P, Barkin JS, (2009) Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 15: 1554-1580.
3. Bartlett JG CT, Gurwith M, Gorbach SL, Onderdonk AD, (1978) Antibiotic-accosicated, pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298: 531-534.
4. McFarland LV MM, Kwok RY, Stamm WE, (1989) Nosocomial acquisition oClostridium difficile infection. N Engl J Med 320: 204-210.
5. Dubberke ER, McMullen KM, Mayfield JL, Reske KA, Georgantopoulos P, et al. (2009) Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol 30: 332-337.
6. Dubberke ER, Wertheimer AI, (2009) Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 30: 57-66.
7. Kyne L, Hamel MB, Polavaram R, Kelly CP, (2002) Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34: 346-353.
8. McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, et al. (2011) The economic burden of Clostridium difficile. Clin Microbiol Infect.
9. Huang H, Weintraub A, Fang H, Nord CE, (2009) Antimicrobial resistance in Clostridium difficile. Int J Antimicrob Agents 34: 516-522.
10. Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK, et al. (2010) Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol 192: 4904-4911.
11. Cookson B, (2007) Hypervirulent strains of Clostridium difficile. Postgrad Med J 83: 291-295.
12. Von Eichel-Streiber C SM, Thlestam M, (1996) Large clostridial cytotoxins a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol 4: 375-382.
13. Jank T, Aktories K, (2008) Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends in Microbiology 16: 222-229.
14. Mathieu R, Lim J, Simpson P, Prasannan S, Fairweather N, et al. (2003) Resonance assignment and topology of a clostridial repetitive oligopeptide (CROP) region of toxin A from Clostridium difficile. J Biomol NMR 25: 83-84.
15. Frisch C, Gerhard R, Aktories K, Hofmann F, Just I, (2003) The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis. Biochem Biophys Res Commun 300: 706-711.
16. Ho JG, Greco A, Rupnik M, Ng KK, (2005) Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc Natl Acad Sci U S A 102: 18373-18378.
17. Giesemann T, Jank T, Gerhard R, Maier E, Just I, et al. (2006) Cholesterol-dependent pore formation of Clostridium difficile toxin A. Naunyn-Schmiedebergs Archives of Pharmacology 372: 125-125.
18. Pfeifer G, Schirmer J, Leemhuis J, Busch C, Meyer DK, et al. (2003) Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J Biol Chem 278: 44535-44541.
19. Kaiser E, Kroll C, Ernst K, Schwan C, Popoff M, et al. (2011) Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90. Infect Immun 79: 3913-3921.
20. Genisyuerek S, Papatheodorou P, Guttenberg G, Schubert R, Benz R, et al. (2011) Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B. Mol Microbiol 79: 1643-1654.
21. Egerer M, Jank T, Giesemann T, Aktories K, (2008) Cysteine protease activity is responsible for autocatalytic cleavage of Clostridium difficile toxin A and B. Naunyn-Schmiedebergs Archives of Pharmacology 377: 11-16.
22. Shen A, Lupardus PJ, Gersch MM, Puri AW, Albrow VE, et al. (2011) Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins. Nat Struct Mol Biol 18: 364-371.
23. Egerer M, Giesemann T, Jank T, Satchell KJF, Aktories K, (2007) Auto-catalytic cleavage of Clostridium difficile toxins a and B depends on cysteine protease activity. Journal of Biological Chemistry 282: 25314-25321.
24. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, et al. (1995) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375: 500-503.
25. Ivarsson ME, Leroux J-C, Castagner B, (2012) Therapien gegen Bakterientoxine. Angewandte Chemie 124: 4098-4121.
26. Dawson LF, Valiente E, Donahue EH, Birchenough G, Wren BW, (2011) Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants. PLoS One 6: e25754.
27. Lanis JM, Hightower LD, Shen A, Ballard JD, (2012) TcdB from hypervirulent Clostridium difficile exhibits increased efficiency of autoprocessing. Mol Microbiol. 84: 66-76.
28. Abdeen SJ, Swett RJ, Feig AL, (2010) Peptide inhibitors targeting Clostridium difficile toxins A and B. ACS Chem Biol 5: 1097-1103.
29. Reinert DJ, Jank T, Aktories K, Schulz GE, (2005) Structural basis for the function of Clostridium difficile toxin B. Journal of Molecular Biology 351: 973-981.
30. Egerer M, Jank T, Giesemann T, Aktories K, (2007) Involvement of cysteine residues in processing of Clostridium difficile toxins A and B. Naunyn-Schmiedebergs Archives of Pharmacology 375: 93-93.
31. Müller S, von Eichel-Streiber C, Moos M, (1999) Impact of amino acids 22-27 of Rho-subfamily GTPases on glucosylation by the large clostridial cytotoxins TcsL-1522, TcdB-1470 and TcdB-8864. European Journal of Biochemistry 266: 1073-1080.
32. Jank T, Giesemann T, Aktories K, (2007) Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding. Journal of Biological Chemistry 282: 35222-35231.
33. Geissler B, Tungekar R, Satchell KJF, (2010) Identification of a conserved membrane localization domain within numerous large bacterial protein toxins. Proceedings of the National Academy of Sciences of the United States of America 107: 5581-5586.
34. Jank T, Aktories K, (2006) Chance of a single amino acid residue turns RhoD into a substrate of Clostridium difficile toxin B. Naunyn-Schmiedebergs Archives of Pharmacology 372: 55-56.
35. Jank T, Pack U, Giesemann T, Schmidt G, Aktories K, (2006) Exchange of a single amino acid switches the substrate properties of RhoA and RhoD toward glucosylating and transglutaminating toxins. Journal of Biological Chemistry 281: 19527-19535.
36. Jank T, Reinert DJ, Giesemann T, Schulz GE, Aktories K, (2005) Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis. Journal of Biological Chemistry 280: 37833-37838.
37. Flores SC, Keating KS, Painter J, Morcos F, Nguyen K, et al. (2008) HingeMaster: Normal mode hinge prediction approach and integration of complementary predictors. Proteins-Structure Function and Bioinformatics 73: 299-319.
38. Keating KS, Flores SC, Gerstein MB, Kuhn LA, (2009) StoneHinge: Hinge prediction by network analysis of individual protein structures. Protein Science 18: 359-371.
39. Suhre K, Sanejouand YH, (2004) ElNemo: a normal mode web server for protein movement analysis and the generation of templates for molecular replacement. Nucleic Acids Research 32: W610-W614.
40. Grant BJ, McCammon JA, Gorfe AA, (2010) Conformational selection in G-proteins: lessons from Ras and Rho. Biophys J 99: L87-89.
41. Wei Y, Zhang Y, Derewenda U, Liu X, Minor W, et al. (1997) Crystal structure of RhoA-GDP and its functional implications. Nature Structural Biology 4: 699-703.
42. Izaguirre JA, Catarello DP, Wozniak JM, Skeel RD, (2001) Langevin stabilization of molecular dynamics. Journal of Chemical Physics 114: 2090-2098.
43. Offen W, Martinez-Fleites C, Yang M, Kiat-Lim E, Davis BG, et al. (2006) Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification. EMBO J 25: 1396-1405.
44. Jiang JY, Lazarus MB, Pasquina L, Sliz P, Walker S, (2012) A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase. Nature Chemical Biology 8: 72-77.
45. Krebs WG, Alexandrov V, Wilson CA, Echols N, Yu HY, et al. (2002) Normal mode analysis of macromolecular motions in a database framework: Developing mode concentration as a useful classifying statistic. Proteins-Structure Function and Genetics 48: 682-695.
46. Ma J, (2005) Usefulness and limitations of normal mode analysis in modeling dynamics of biomolecular complexes. Structure 13: 373-380.
47. Debrunner PG, Frauenfelder H, (1982) Dynamics of Proteins. Annual Review of Physical Chemistry 33: 283-299.
48. Petsko GA, Ringe D, (1984) Fluctuations in Protein-Structure from X-Ray-Diffraction. Annual Review of Biophysics and Bioengineering 13: 331-371.
49. Pruitt RN, Chumbler NM, Rutherford SA, Farrow MA, Friedman DB, et al. (2012) Structural Determinants of Clostridium difficile Toxin A Glucosyltransferase Activity. J Biol Chem 287: 8013-8020.
50. Lyskov S, Gray JJ, (2008) The RosettaDock server for local proteinprotein docking. Nucleic Acids Research 36: W233-W238.
51. Ritchie DWKDaVS, (2005) High Order Analytic Translation Matrix Elements For Real Space Six-Dimensional Polar Fourier Correlations. J Appl Crystl 38: 808-818.
52. Patel S, Brooks CL 3rd (2004) CHARMM fluctuating charge force field for proteins: I parameterization and application to bulk organic liquid simulations. J Comput Chem 25: 1-15.
53. Patel S, Mackerell AD Jr, Brooks CL 3rd (2004) CHARMM fluctuating charge force field for proteins: II protein/solvent properties from molecular dynamics simulations using a nonadditive electrostatic model. J Comput Chem 25: 1504-1514.
54. Brooks BR, Brooks CL 3rd, Mackerell AD Jr, Nilsson L, Petrella RJ, et al (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30: 1545-1614.
55. Sapay N, Tieleman DP, (2010) Combination of the CHARMM27 force field with united-atom lipid force fields. J Comput Chem. 32: 1400-1410.
56. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, et al. (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26: 1781-1802.
57. Humphrey W, Dalke A, Schulten K, (1996) VMD: Visual molecular dynamics. Journal of Molecular Graphics 14: 33-37.
58. Wang H, Dommert F, Holm C, (2010) Optimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiency. Journal of Chemical Physics 133: 034117.
59. Darden T, York D, Pedersen L, (1993) Particle Mesh Ewald-an N.Log(N) Method for Ewald Sums in Large Systems. Journal of Chemical Physics 98: 10089-10092.
60. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A Smooth Particle Mesh Ewald Method. Journal of Chemical Physics 103: 8577-8593.
61. Wriggers W, Kate A, Shan Y, Piana-Agostinetti S, Maragakis P, (2009) Automated Event Detection and Activity Monitoring in Long Time-Scale Molecular Dynamics. J Chem Theory Comput 5: 2595-2605.
62. Wolfram Research I, (2010) Mathematica Edition: Version 8.0. Champaign, Illinois: Wolfram Research, Inc.